Integration of Chromogenic RNAscope In Situ Hybridization for Target Validation in Drug Discovery
Rosanna Win1, Wesley Minto1, In Kyoung Mah1
1Gilead Sciences, Foster City, California, USA.
Abstract:
Characterizing the expression of novel targets in normal and diseased tissues is a fundamental component of a target validation data package. Often these targets are presented to the pathology team for assessment with bulk or single-cell RNAseq data and limited to no spatial tissue expression data. In situ hybridization to detect mRNA (RNAscope) is a valuable tool to (1) identify cells that may express the target protein and to corroborate protein expression during immunohistochemical (IHC) assay development or (2) to use as surrogate for single-cell expression IHC when antibodies are not available. Chromogenic RNAscope in situ hybridization (CISH) can be performed on frozen or formalin-fixed, paraffin-embedded (FFPE) tissues. This CISH workflow starts with RNA qualification of the tissue (to assess RNA integrity) by measuring the expression of housekeeping genes. RNA-qualified tissues then undergo CISH for the target in question, and positive CISH signals are quantified in VisioPharm by a combination of color deconvolution, size gating, and dot density thresholding. This RNA workflow can complement IHC or standalone in target validation for spatial characterization of novel targets.
Insights
Novel RNAscope in situ hybridization (ISH) methods enable spatial characterization of gene expression in tissues. This technique complements immunohistochemistry (IHC) for target validation and spatial analysis.
Area of Science:
- Biopathology
- Molecular Pathology
- Genomics
Background:
- Target validation requires characterizing novel targets in normal and diseased tissues.
- Traditional methods like RNA sequencing lack spatial expression data.
- Immunohistochemistry (IHC) is common but requires specific antibodies.
Purpose of the Study:
- To present a Chromogenic RNAscope in situ hybridization (CISH) workflow for spatial gene expression analysis.
- To demonstrate CISH as a valuable tool for target validation and spatial characterization.
- To highlight CISH as a complement or alternative to IHC.
Main Methods:
- RNAscope ISH workflow on frozen or FFPE tissues.
- Initial RNA quality assessment using housekeeping genes.
- CISH for target mRNA detection.
- Quantification of CISH signals using VisioPharm software (color deconvolution, size gating, dot density thresholding).
Main Results:
- The CISH workflow successfully detects and quantifies mRNA expression spatially within tissues.
- RNA qualification ensures reliable assay performance.
- Quantification methods allow for objective assessment of target expression.
Conclusions:
- CISH is an effective method for spatial characterization of novel targets.
- This workflow can support IHC assay development or serve as a surrogate for single-cell IHC.
- The presented RNA workflow is valuable for target validation in pathology.
More Related Videos
Related Concept Videos
In-situ Hybridization
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...
FISH - Fluorescent In-situ Hybridization
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...


